Related Experiment Video
Updated: Dec 8, 2025

Directed Differentiation of Induced Pluripotent Stem Cells towards T Lymphocytes
Published on: May 14, 2012
Translation control can shape TP53-dependent cell fate
Dario Rizzotto1, Sara Zaccara1, Annalisa Rossi1
1Department of Cellular, Computational and Integrative Biology, CIBIO, University of Trento, Trento, Italy.
Abstract:
The search for mechanisms underlying different cellular responses to the treatment with Nutlin-3, an MDM2 inhibitor that unleashes p53, revealed a translational control mechanism involving the RNA binding proteins PCBP2 and, particularly, DHX30. Sifting through a multi-functional p53-dependent transcriptional output, this translational control can modulate the activation of cell death pathways.
Insights
Nutlin-3 treatment unleashes p53, revealing a translational control mechanism. RNA binding proteins PCBP2 and DHX30 modulate cell death pathways via p53-dependent transcription.
Area of Science:
- Molecular Biology
- Cellular Biology
- Cancer Research
Background:
- Nutlin-3 is an MDM2 inhibitor that activates the p53 tumor suppressor.
- Cellular responses to p53 activation can vary, indicating complex regulatory mechanisms.
- Understanding these mechanisms is crucial for developing targeted cancer therapies.
Purpose of the Study:
- To investigate the mechanisms controlling cellular responses to Nutlin-3.
- To identify key regulatory factors involved in p53-mediated cellular processes.
- To elucidate how translational control impacts cell death pathways.
Main Methods:
- Utilized Nutlin-3 to activate p53 in cellular models.
- Employed RNA-binding protein analysis to identify key players.
- Investigated p53-dependent transcriptional and translational outputs.
- Assessed the modulation of cell death pathway activation.
Main Results:
- Discovered a translational control mechanism involving RNA binding proteins.
- Identified PCBP2 and DHX30 as critical components of this mechanism.
- Demonstrated that this control modulates the activation of cell death pathways.
- Linked translational control to the broader p53-dependent transcriptional output.
Conclusions:
- Translational control, mediated by PCBP2 and DHX30, is a key regulator of cellular responses to p53 activation.
- This mechanism fine-tunes the activation of cell death pathways.
- Findings offer new insights into p53-driven cancer biology and therapeutic strategies.
Related Concept Videos
Lineage Commitment
Abnormal Proliferation
Forced Transdifferentiation
Artificial...
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Negative Regulator Molecules
Replicative Cell Senescence

